← FDA DRUG APPROVALS

FDA NDA · NDA019762

TESTODERM

Sponsor: ALZA

APPLICATION
NDA019762
TYPE
NDA
ORIGINAL APPROVAL
1993-10-12
LATEST ACTION
1997-12-17
ROUTE
TRANSDERMAL
DOSAGE FORM
FILM, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

TESTODERMDiscontinued
TESTOSTERONE 4MG/24HR · FILM, EXTENDED RELEASE · TRANSDERMAL
TESTODERMDiscontinued
TESTOSTERONE 6MG/24HR · FILM, EXTENDED RELEASE · TRANSDERMAL

Approval history

1997-12-17Manufacturing (CMC) · Supplement 5 · standardAP
1997-05-12Manufacturing (CMC) · Supplement 4 · standardAP
1996-06-26Manufacturing (CMC) · Supplement 1 · standardAP
1996-05-28Labeling · Supplement 2 · standardAP
1993-10-12Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →